$5.32+0.04 (+0.76%)
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
Nu Skin Enterprises, Inc. in the Consumer Defensive sector is trading at $5.32 with a market capitalization of $248M. The stock is currently near its 52-week low of $4.89, remaining 39.1% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $320.61Mβ | $370.32Mβ | $364.21Mβ | $386.14Mβ | $364.49M |
| Gross Profit | $214.46Mβ | $261.98Mβ | $256.72Mβ | $265.73Mβ | $246.96M |
| Operating Income | $5.87Mβ | $23.24Mβ | $21.64Mβ | $30.78Mβ | $15.21M |
| Net Income | $1.84Mβ | $14.49Mβ | $17.08Mβ | $21.12Mβ | $107.52M |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiS...
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EL, ELF, HELE and NUS are leveraging innovation, digital tools and strong beauty demand as the cosmetics industry navigates cost pressures.
EL, ELF, HELE and NUS are benefiting from growing skincare demand, product innovation and expanding digital channels.
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backed by valuation and debt filters.
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with balance-sheet and value checks for upside.